OpenAI's ChatGPT has passed the United States Medical Licensing Exam.
OpenAI's ChatGPT has passed the United States Medical Licensing Exam
1/29/2023
It was found that ChatGPT “performed at or near the passing threshold” on the United States Medical Licensing Exam (USMLE), adding that it demonstrated a high level of concordance and insight in its explanations to the answers.
“These results suggest that large language models may have the potential to assist with medical education, and potentially, clinical decision-making,” the researchers’ wrote.
The chatbot is also said to have demonstrated “high internal concordance,” with its answers and explanations scoring 94.6% concordance across all questions as reviewed by two physician adjudicators.
“Our findings can be organized into two major themes: (1) the rising accuracy of ChatGPT, which approaches or exceeds the passing threshold for USMLE; and (2) the potential for this AI to generate novel insights that can assist human learners in a medical education setting,” the researchers wrote.
Elon Musk has said: In November next year, we fire all politicians who betrayed the American people
6/4/2025 12:38 AMPresident Trump's Truth Social, DJT, files for Bitcoin ETF
6/4/2025 12:36 AMTrump's "Big Beautiful Bill" bans all 50 states from regulating AI for 10 years, centralizes control at the federal level, and integrates AI systems into key federal agencies
6/4/2025 12:34 AMQuantum computing could break bitcoin-like encryption far easier than intially thought, Google, GOOGL, researcher says
6/3/2025 5:39 PM
Stay Updated
Subscribe to our newsletter for the latest financial insights and news.
Unusual Whales does not confirm the information's truthfulness or accuracy of the associated references, data, and cannot verify any of the information. Any content on this site or related pages are not intended to provide legal, tax, investment or insurance advice. Unusual Whales Inc. is not registered as a securities broker-dealer or an investment adviser with the U.S. Securities and Exchange Commission, the Financial Industry Regulatory Authority (“FINRA”) or any state securities regulatory authority. Nothing on Unusual Whales should be construed as an offer to sell, a solicitation of an offer to buy, or a recommendation for any security by Unusual Whales or any third party. Options, investing, trading is risky, and losses are more expected than profits. Please do own research before investing. Please only subscribe after reading our full terms and understanding options and the market, and the inherent risks of trading. It is highly recommended not to trade on this, or any, information from Unusual Whales. Markets are risky, and you will likely lose some or all of your capital. Please check our terms for full details.
Any content on this site or related pages are not intended to provide legal, tax, investment or insurance advice. Unusual Whales Inc. is not registered as a securities broker-dealer or an investment adviser with the U.S. Securities and Exchange Commission, the Financial Industry Regulatory Authority (“FINRA”) or any state securities regulatory authority. Nothing on Unusual Whales should be construed as an offer to sell, a solicitation of an offer to buy, or a recommendation for any security by Unusual Whales or any third party. Certain investment planning tools available on Unusual Whales may provide general investment education based on your input. You are solely responsible for determining whether any investment, investment strategy, security or related transaction is appropriate for you based on your personal investment objectives, financial circumstances and risk tolerance. You should consult your legal or tax professional regarding your specific situation. See terms for more information.